L19IL2 Clinical Trials
2 recruitingDrug
Phase 21Phase 11
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study to Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination With L19-IL2 as a Treatment of Metastatic FAP-positive Solid Tumors
FAP
Philogen S.p.A.56 enrolled4 locationsNCT06640413
Recruiting
Phase 2
Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients
Melanoma Stage IVMelanoma Stage III
Philogen S.p.A.162 enrolled1 locationNCT06284590